Chengda Biotech announced that due to Shaoguan Gao Teng's offer to acquire the company's shares, trading of the company's shares will be suspended for one day on April 7, 2025. The tender offer period is from March 5, 2025 to April 3, 2025. The planned number of shares to be purchased is 184 million shares, accounting for 44.18% of the company's total share capital, and the offer purchase price is 25.51 yuan/share. During the suspension period, the company will promptly fulfill its information disclosure obligations in accordance with relevant regulations and resume trading on the day the results of the proposed acquisition are announced.

Chengda Biotech announced that due to Shaoguan Gao Teng's offer to acquire the company's shares, trading of the company's shares will be suspended for one day on April 7, 2025. The tender offer period is from March 5, 2025 to April 3, 2025. The planned number of shares to be purchased is 184 million shares, accounting for 44.18% of the company's total share capital, and the offer purchase price is 25.51 yuan/share. During the suspension period, the company will promptly fulfill its information disclosure obligations in accordance with relevant regulations and resume trading on the day the results of the proposed acquisition are announced.